New law creates national strategy to assess the quality of private healthcare services
Law No. 15,524, published on September 29, 2026 and already in force, creates the National Strategy for Control and Assessment of the Quality of Healthcare Provided by the Private Sector. In practice, private hospitals, clinics and other providers will be assessed against standards set by the Brazilian Health Regulatory Agency (Anvisa), with results periodically disclosed […]
ANVISA modernizes sanitary safety in airports and aircraft
I. Regulatory context and paradigm shift The Board of Directors of the Brazilian Health Regulatory Agency issued Board Resolution (RDC) No. 1,038/2026, which addresses sanitary safety in airports and aircraft and establishes obligations for airport operators, airlines and third-party service providers. The rule fully revokes RDC No. 2, of January 8, 2003, which had approved […]
ANVISA initiates regulatory process for the sale of medicines through digital platforms
Introduction On August 19, 2026, the Board of Directors of the Brazilian Health Regulatory Agency (ANVISA) unanimously approved the opening of a regulatory process to establish the health rules applicable to the engagement of digital platforms and marketplaces by pharmacies and drugstores for the logistics and delivery of medicines to consumers. The decision marks the […]
Life Sciences & Healthcare
Rafael Calheiros Bertão
Ana Luiza Calil
Esther Flesch
Marília Veiga Ravazzi
